Literature DB >> 19635628

Trends in mortality of pulmonary embolism--an international comparison.

Barbara Hoffmann1, Christian R Gross, Karl-Heinz Jöckel, Knut Kröger.   

Abstract

BACKGROUND: Evidence from several clinical and epidemiological studies suggests a decreasing incidence and mortality of pulmonary embolism (PE), but results are still controversial. We analysed time trends of fatal pulmonary embolism in several countries across Europe and North America.
METHODS: We extracted age-, sex-, and country-specific number of deaths due to PE (415.1 ICD-9; I26 ICD-10) from 1980 to 2004 as available from the WHO mortality database, which comprises mortality data and population density in 5-year age groups based on national vital statistics. Yearly age- and sex-standardised mortality rates and their 95% confidence intervals for PE were calculated. We compared overall and sex-specific age-standardised mortality rates across different European countries and the USA over time.
RESULTS: Age- and sex-standardised PE-specific mortality in 1990 varied between 2.7/100,000 (2.5-3.0/100,000) in The Netherlands and 12.8/100,000 (12.0-13.5/100,000) in Austria. While in most countries PE mortality decreased over time, PE mortality increased distinctly in Poland from 4.0/100,000 (3.75-4.27/100,000) to 7.7/100,000 (7.45-8.03/100,000) in 2003. In Germany, we observed a continuous slight increase and in The Netherlands no clear change of PE mortality was seen. DISCUSSION: While comparison of cause of death data over time and across countries should be undertaken with caution due to inaccuracies in assigning the cause of death and national conventions in coding, the general trend of a decline in PE mortality could not be shown in several European countries. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19635628     DOI: 10.1016/j.thromres.2009.06.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany.

Authors:  Carolin Pütter; Olga von Beckerath; Hanna Maria Sobik; Holger Reinecke; Jürgen Stausberg; Knut Kröger
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

2.  [High risk pulmonary embolism. Case report of a successful embolectomy].

Authors:  J Kalbhenn; T Loop; C A Stahl
Journal:  Anaesthesist       Date:  2011-11       Impact factor: 1.041

3.  Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France.

Authors:  Aurore Tricotel; Fanny Raguideau; Cédric Collin; Mahmoud Zureik
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

4.  Time trends for pulmonary embolism incidence in Greece.

Authors:  Dimitrios G Raptis; Konstantinos I Gourgoulianis; Zoe Daniil; Foteini Malli
Journal:  Thromb J       Date:  2020-01-23

5.  [Trends in mortality related to pulmonary embolism in the DACH countries].

Authors:  Lukas Hobohm; Tim Sebastian; Luca Valerio; Seyed Hamidreza Mahmoudpour; Georgios Vatsakis; Fabian Johner; Karsten Keller; Thomas Münzel; Nils Kucher; Stavros V Konstantinides; Stefano Barco
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-08-24       Impact factor: 1.552

6.  Impact of rescue-thrombolysis during cardiopulmonary resuscitation in patients with pulmonary embolism.

Authors:  Fikret Er; Amir M Nia; Natig Gassanov; Evren Caglayan; Erland Erdmann; Uta C Hoppe
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

7.  Pulmonary Embolism Mortality in Brazil from 1989 to 2010: Gender and Regional Disparities.

Authors:  Eduardo Sahade Darze; Juliana Borges Casqueiro; Luisa Allen Ciuffo; Jessica Mendes Santos; Iuri Resedá Magalhães; Adriana Lopes Latado
Journal:  Arq Bras Cardiol       Date:  2015-11-10       Impact factor: 2.000

8.  Long-term outcomes in patients with acute pulmonary embolism after in-hospital treatment: study protocol of the prospective Lungenembolie Augsburg Studie (LEA study).

Authors:  Christa Meisinger; Jakob Linseisen; Inge Kirchberger; Wolfgang von Scheidt; Thomas M Berghaus
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.